Please login to the form below

Not currently logged in
Email:
Password:

NMOSD

This page shows the latest NMOSD news and features for those working in and with pharma, biotech and healthcare.

Roche’s Soliris rival Enspryng bags FDA approval

Roche’s Soliris rival Enspryng bags FDA approval

It is also indicated for use in adult NMOSD patients who are AQP4 antibody positive. ... The new NMOSD treatment was originally designed by Roche’s Japanese subsidiary Chugai, using novel recycling antibody technology.

Latest news

More from news
Approximately 4 fully matching, plus 6 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics